Literature DB >> 14755459

Screening adherence in BRCA1/2 families is associated with primary physicians' behavior.

Susan T Tinley1, Julia Houfek, Patrice Watson, Lari Wenzel, Mary Beth Clark, Susan Coughlin, Henry T Lynch.   

Abstract

This study provides an assessment of long-term breast and ovarian cancer screening behaviors and the variables associated with adherence with screening among women with or at 50% for having a BRCA1/2 mutation. Participants in the study included 112 women (33 mutation carriers and 79 at 50% risk). Data was collected through a mailed questionnaire, which included items to assess screening behaviors in the last 2 years, risk perception, cancer specific distress, adherence determinants, specific barriers, and cancer history. Statistical analysis included descriptive statistics and non-parametric tests to describe bivariate associations and regression analysis. Adherence rates were 72% for annual mammography, 21% for semi-annual clinical breast exam (CBE), 29% for monthly breast self-exam (BSE), and 19% for annual transvaginal ultrasound (US). Only one participant was adherent with semi-annual CA125. Variables that had a significant association (P < 0.05) with at least one screening modality included: a lack of time, marital status, education, cancer history, provider concern, perceived screening utility, confidence in ability to overcome barriers, cancer specific distress, and risk perception. Primary physician behavior, either in terms of screening recommendations or screening performance in the case of CBE, had significant independent association with adherence to mammography, CBE, and US screening recommendations. The results of this study highlight the essential role that primary physicians play in supporting their very high-risk patients' adherence. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755459     DOI: 10.1002/ajmg.a.20431

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling.

Authors:  Sharon L Bober; Lizbeth A Hoke; Rosemary B Duda; Nadine M Tung
Journal:  J Genet Couns       Date:  2007-08-04       Impact factor: 2.537

2.  Screening behavior in women at increased familial risk for breast cancer.

Authors:  Yoland C Antill; John Reynolds; Mary Anne Young; Judy A Kirk; Katherine M Tucker; Tarli L Bogtstra; Shirley S Wong; Tracy E Dudding; Juliana L Di Iulio; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2006-07-07       Impact factor: 2.375

Review 3.  Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer.

Authors:  J R J De Leeuw; M J van Vliet; M G E M Ausems
Journal:  Fam Cancer       Date:  2008-03-14       Impact factor: 2.375

4.  Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

Authors:  C L Scherr; N M Lindor; T L Malo; F J Couch; S T Vadaparampil
Journal:  Clin Genet       Date:  2015-02-26       Impact factor: 4.438

5.  Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population.

Authors:  Michel Dorval; Karine Bouchard; Elizabeth Maunsell; Marie Plante; Jocelyne Chiquette; Stéphanie Camden; Michel J Dugas; Jacques Simard
Journal:  J Genet Couns       Date:  2008-05-15       Impact factor: 2.537

6.  An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data.

Authors:  Stephanie A Cohen; Courtney Lynam Scherr; Dawn M Nixon
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

7.  Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.

Authors:  K Ready; B K Arun; K M Schmeler; A Uyei; J K Litton; K H Lu; C C Sun; S K Peterson
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

8.  Mammography FastTrack: an intervention to facilitate reminders for breast cancer screening across a heterogeneous multi-clinic primary care network.

Authors:  William T Lester; Jeffrey M Ashburner; Richard W Grant; Henry C Chueh; Michael J Barry; Steven J Atlas
Journal:  J Am Med Inform Assoc       Date:  2008-12-11       Impact factor: 4.497

9.  Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome.

Authors:  Shilpa Grover; Elena M Stoffel; Rowena C Mercado; Beth M Ford; Wendy K Kohlman; Kristen M Shannon; Peggy G Conrad; Amie M Blanco; Jonathan P Terdiman; Stephen B Gruber; Daniel C Chung; Sapna Syngal
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

10.  Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 families.

Authors:  Christelle Duprez; Véronique Christophe; Isabelle Milhabet; Aurélie Krzeminski; Claude Adenis; Pascaline Berthet; Jean-Philippe Peyrat; Philippe Vennin
Journal:  J Genet Couns       Date:  2013-01-25       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.